Jaguar Health Announces Topline Results of Investigator-Initiated Phase 2 Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients
Stock Information for Jaguar Health Inc.
Loading
Please wait while we load your information from QuoteMedia.